Jul 28, 2026 08:02AM
Jul 28, 2026 08:00AM
Jun 2, 2026 09:00AM
May 28, 2026 07:45AM
May 28, 2026 07:45AM
May 19, 2026 08:04AM
May 19, 2026 08:00AM BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
May 15, 2026 04:05PM
Mar 31, 2026 04:01PM
Feb 26, 2026 06:23AM
Feb 26, 2026 06:22AM
Feb 20, 2026 06:01AM
Feb 20, 2026 06:00AM
Nov 14, 2025 04:30PM BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Aug 14, 2025 07:02AM
Aug 8, 2025 07:00AM
Jul 17, 2025 04:31PM
Jul 17, 2025 04:30PM
Jul 17, 2025 04:30PM
Jul 8, 2025 07:01AM
Jul 8, 2025 07:00AM FDA Review of Citizen Petition Offers a Fresh Look at NurOwn®'s Evidence of Treatment Effectiveness
Jun 16, 2025 08:30AM
May 27, 2025 07:04AM
May 27, 2025 07:00AM
May 19, 2025 07:01AM
May 19, 2025 07:00AM
May 15, 2025 04:05PM
May 15, 2025 07:30AM BrainStorm Reschedules First Quarter 2025 Financial Results Release to Post-Market Close Today and Sets Investor Call for Monday, May 19
May 7, 2025 06:30AM
May 6, 2025 07:00AM
Apr 29, 2025 06:30AM
Apr 10, 2025 07:30AM
Apr 10, 2025 07:30AM
Mar 31, 2025 07:00AM
Mar 26, 2025 08:15AM Brainstorm Cell Therapeutics (BCLI) Granted Compliance Extension from Nasdaq
Mar 26, 2025 08:15AM
Mar 24, 2025 07:00AM
Dec 30, 2024 08:00AM
Dec 30, 2024 08:00AM
Dec 9, 2024 07:00AM
Dec 3, 2024 07:05AM
Dec 3, 2024 07:00AM BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology
Dec 2, 2024 07:00AM
Nov 14, 2024 04:30PM
Nov 11, 2024 06:00AM
Oct 30, 2024 07:58AM
Oct 30, 2024 06:01AM
Oct 30, 2024 06:00AM
Oct 28, 2024 06:00AM BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting
Oct 7, 2024 07:00AM

327,953 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All